Seoul, South Korea

Woo Jae Jung

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Dong Kook Pharm Co., Ltd. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Woo Jae Jung: Innovator in Pharmaceutical Composition for Hearing Loss

Introduction

Woo Jae Jung is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hearing loss. His innovative approach utilizes natural ingredients, showcasing the potential of avocado oil in medical applications.

Latest Patents

Woo Jae Jung holds a patent for a pharmaceutical composition that contains an avocado oil fraction as an active ingredient for the prevention or treatment of hearing loss. This invention specifically highlights the isopropanol fraction of avocado oil, which has been shown to significantly increase the number of hair cells reduced by neomycin in zebrafish models. This discovery suggests that the isopropanol fraction of avocado oil can be favorably used in the treatment of hearing loss.

Career Highlights

Woo Jae Jung is associated with Dong Kook Pharm Co., Ltd., where he continues to develop innovative pharmaceutical solutions. His work is characterized by a commitment to improving health outcomes through research and development.

Collaborations

He collaborates with talented coworkers, including Bin Na Hong and Kye Wan Lee, who contribute to his research efforts and the advancement of their projects.

Conclusion

Woo Jae Jung's contributions to the field of pharmaceuticals, particularly in the treatment of hearing loss, highlight the importance of innovation in healthcare. His work with avocado oil fractions represents a promising avenue for future research and development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…